Chemotherapy-induced neuropathy and pain in pediatric oncology patients: impact of combination therapies.
Delia SorianoGisella Santos ChoclerMariana Alejandra VarelaMaría Florencia CoronelPublished in: European journal of pediatrics (2024)
• Prevalence of symptomatic CIPN is 23% among pediatric patients undergoing treatment for hematopoietic tumors in a referral hospital in Argentina. Most patients report moderate or severe pain. • Combining vincristine with cytarabine and using a higher number of neurotoxic drugs in combination therapies exhibit significant association with the development of CIPN-related symptoms.
Keyphrases
- end stage renal disease
- chemotherapy induced
- patients undergoing
- ejection fraction
- newly diagnosed
- chronic pain
- chronic kidney disease
- peritoneal dialysis
- healthcare
- prognostic factors
- palliative care
- primary care
- neuropathic pain
- low dose
- early onset
- physical activity
- depressive symptoms
- patient reported
- smoking cessation
- adverse drug